# US 2013/0273625 A1 · Methods for increasing microbial production of isoprene, isoprenoids, and isoprenoid precursor molecules using glucose and acetate co-metabolism

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2013/0273625 A1
- Document ID: US20130273625A1
- Status: Published application
- Kind: A1
- Application number: 13/646,556
- Filed: 2012-10-05
- Published: 2013-10-17
- Earliest claimed: 2011-10-07
- Assignees: Danisco US Inc.
- Applicants: Danisco US Inc.
- Inventors: Gopal K. CHOTANI; Alex T. NIELSEN; Dmitrii V. VAVILINE
- Web page: https://patentgrep.com/patent/US20130273625A1

## CPC

- C12P 5/007: {containing one or more isoprene units, i.e. terpenes (carotenes C12P23/00)}
- C12P 5/026: {Unsaturated compounds, i.e. alkenes, alkynes or allenes}
- C12P 7/04: acyclic
- C12P 7/42: Hydroxy-carboxylic acids
- C12P 9/00: Preparation of organic compounds containing a metal or atom other than H, N, C, O, S or halogen {(phosphoglycerides, C12P7/6481)}
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}

## Abstract

Provided herein are methods for the increased production of intracellular acetyl-CoA, mevalonate, isoprenoid precursors, isoprene and/or isoprenoids by recombinant microorganisms via co-metabolism of substrates with varied oxidation levels.

## Claims

### Claim 1

A method for improving the efficiency of the production of isoprene by recombinant host cells in culture, the method comprising culturing said recombinant host cells in culture media comprising a carbon source and acetate under suitable conditions for the production of isoprene,
wherein said recombinant host cells comprise one or more heterologous nucleic acids encoding an isoprene synthase polypeptide;
wherein said recombinant host cells are capable of producing isoprene; and
wherein isoprene production by said recombinant host cells cultured in the culture media comprising a carbon source and acetate is improved compared to the isoprene production by said recombinant host cells cultured in culture media comprising a carbon source in the absence of acetate.

### Claim 2 (depends on 1)

The method of claim 1, wherein said improved production of isoprene is characterized by an increase in: (i) the specific productivity, (ii) the cumulative yield, (iii) the cumulative yield, or (iv) Cell Productivity Index.

### Claim 3 (depends on 2)

The method of claim 2, wherein said improved production of isoprene is characterized by an increase in the specific productivity.

### Claim 4 (depends on 2)

The method of claim 2, wherein said improved production of isoprene is characterized by an increase in the cumulative yield.

### Claim 5 (depends on 2)

The method of claim 2, wherein said improved production of isoprene is characterized by an increase in the cumulative yield.

### Claim 6 (depends on 2)

The method of claim 2, wherein said improved production of isoprene is characterized by an increase in the Cell Productivity Index.

### Claim 7 (depends on 1)

The method of claim 1, wherein the isoprene synthase polypeptide is a plant isoprene synthase polypeptide.

### Claim 8 (depends on 7)

The method of claim 7, wherein the isoprene synthase polypeptide is a polypeptide from Pueraria or Populus or a hybrid, Populus alba×Populus tremula.

### Claim 9 (depends on 8)

The method of claim 8, wherein the isoprene synthase polypeptide is selected from the group consisting of Pueraria montana or Pueraria lobata, Populus tremuloides, Populus alba, Populus nigra, and Populus trichocarpa.

### Claim 10 (depends on 7)

The method of claim 7, wherein the plant isoprene synthase polypeptide is a kudzu isoprene synthase polypeptide.

### Claim 11 (depends on 1)

The method of claim 1, wherein the cells further comprise one or more heterologous nucleic acid encoding one or more MVA pathway polypeptides.

### Claim 12 (depends on 11)

The method of claim 11, wherein the cells further comprise one or more heterologous nucleic acid encoding the entire MVA pathway.

### Claim 13 (depends on 1)

The method of claim 1, wherein the cells further comprise a heterologous nucleic acid encoding an isopentyl-diphosphate isomerase (IDI) polypeptide.

### Claim 14 (depends on 1)

The method of claim 1, wherein the cells further comprise a heterologous nucleic acid encoding a DXS polypeptide.

### Claim 15 (depends on 1)

The method of claim 1, wherein the recombinant host cells are gram-positive bacterial cells, gram-negative bacterial cells, fungal cells, filamentous fungal cells, algal cells or yeast cells.

### Claim 16 (depends on 1)

The method of claim 1, wherein the recombinant host cells are selected from the group consisting of Bacillus subtilis, Streptomyces lividans, Streptomyces coelicolor, Streptomyces griseus, Escherichia coli, Pantoea citrea, Trichoderma reesei, Aspergillus oryzae and Aspergillus niger, Saccharomyces cerevisieae and Yarrowia lipolytica.

### Claim 17 (depends on 1)

The method of any of claim 1, wherein the concentration of acetate is at least about 0.01% to about 1.5%.

### Claim 18

A method for improving the efficiency of the production of isoprenoid precursors by a recombinant host cell, the method comprising:
a. providing one or more recombinant host cells comprising one or more heterologous nucleic acids encoding one or more MVA pathway polypeptides; and
b. culturing said recombinant host cells in the presence of glucose and acetate under suitable conditions for the production of isoprenoid precursors;
wherein the production of isoprenoid precursors by said recombinant host cells cultured in the presence of glucose and acetate is improved compared to the production of isoprenoid precursors by said recombinant host cells cultured in the presence of glucose alone.

### Claim 19 (depends on 18)

The method of claim 18, wherein said improved production of an isoprenoid precursor is characterized by an increase in: (i) the specific productivity, (ii) yield, or (iii) titer.

### Claim 20 (depends on 18)

The method of claim 18, wherein the isoprenoid precursor is selected from group consisting of mevalonate (MVA), DMAPP or IPP.

### Claim 21 (depends on 18)

The method of claim 18, wherein the isoprenoid precursor is mevalonate (MVA).

### Claim 22 (depends on 18)

The method of claim 18, wherein the one or more heterologous nucleic acids is placed under an inducible promoter or a constitutive promoter.

### Claim 23 (depends on 18)

The method of claim 18, wherein the one or more heterologous nucleic acids is cloned into a multicopy plasmid.

### Claim 24 (depends on 18)

The method of claim 18, wherein the cells are selected from the group consisting of bacterial cells, fungal cells, or algal cells.

### Claim 25

A method for improving the efficiency of the production of isopreniods by recombinant host cells in culture, the method comprising culturing said recombinant host cells in culture media comprising a carbon source and acetate under suitable conditions for the production of isopreniods,
wherein said recombinant host cells comprise (i) one or more heterologous nucleic acid encoding the entire MVA pathway and (ii) one or more heterologous nucleic acids encoding for a polyprenyl pyrophosphate synthase;
wherein said recombinant host cells are capable of producing an isoprenoid; and
wherein isoprenoid production by said recombinant host cells cultured in the presence of glucose and acetate is improved compared to the isoprenoid production by said recombinant host cells cultured in the presence of glucose alone.

### Claim 26 (depends on 25)

The method of claim 25, wherein said improved production of isoprene is characterized by an increase in: (i) the specific productivity, (ii) the cumulative yield, (iii) the cumulative yield, or (iv) Cell Productivity Index.

### Claim 27 (depends on 25)

The method of any one of claim 25, wherein the isoprenoid is selected from group consisting of monoterpenes, diterpenes, triterpenes, tetraterpenes, sequiterpene, and polyterpene.

### Claim 28 (depends on 27)

The method of claim 27, wherein the isoprenoid is a sesquiterpene.

### Claim 29 (depends on 27)

The method of any one of claim 27, wherein the isoprenoid is selected from the group consisting of abietadiene, amorphadiene, carene, α-farnesene, β-farnesene, farnesol, geraniol, geranylgeraniol, linalool, limonene, myrcene, nerolidol, ocimene, patchoulol, β-pinene, sabinene, γ-terpinene, terpindene and valencene.

### Claim 30 (depends on 25)

The method of claim 25, wherein the one or more heterologous nucleic acids is placed under an inducible promoter or a constitutive promoter.

### Claim 31 (depends on 25)

The method of claim 25, wherein the one or more heterologous nucleic acids is cloned into a multicopy plasmid.

### Claim 32 (depends on 25)

The method of claim 25, wherein the cells are selected from the group consisting of bacterial cells, fungal cells, or algal cells.

### Claim 33 (depends on 25)

The method of claim 25, wherein the concentration of acetate is at least about 0.01% to about 1.5%.
